People · Operator

Michael Rittenberg, M.D.

Named in public records as an officer, director or promoter · active 2014–2014 · Other Health Care

1
Companies
1
Filings
$845K
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Kidney Stone Associates, LlcOther Health CarePre-Seed$845K$13.8M2014
Operator network

Michael Rittenberg, M.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Alan Buergenthal · 12 companies · 1 sharedAlan BuergenthalCharles Burns, M.D. · 1 companies · 1 sharedCharles Burns, M.…CHARLES BURNS, MD · 1 companies · 1 sharedCHARLES BURNS, MDIra Grossman, M.D. · 1 companies · 1 sharedIra Grossman, M.D.IRA GROSSMAN, MD · 1 companies · 1 sharedIRA GROSSMAN, MDJames Stefanelli, M.D. · 1 companies · 1 sharedJames Stefanelli,…JAMES STEFANELLI, MD · 1 companies · 1 sharedJAMES STEFANELLI,…JERALD GILBERT, MD · 1 companies · 1 sharedJERALD GILBERT, MDMICHAEL RITTENBERG, MD · 1 companies · 1 sharedMICHAEL RITTENBER…Robert Barrett, M.D. · 1 companies · 1 sharedRobert Barrett, M…Robert Fiorelli, D.O. · 1 companies · 1 sharedRobert Fiorelli, …ROBERT FIORELLI, DO · 1 companies · 1 sharedROBERT FIORELLI, …Kidney Stone Associates, Llc · $0.8M raisedKidney Stone Associat…Michael Rittenberg, M.D.MM
Michael Rittenberg, M.D. Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Michael Rittenberg, M.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Alan Buergenthal112
Robert Fiorelli, D.O.11
Ira Grossman, M.D.11
Robert Barrett, M.D.11
Charles Burns, M.D.11
James Stefanelli, M.D.11
JAMES STEFANELLI, MD11
JERALD GILBERT, MD11
CHARLES BURNS, MD11
ROBERT FIORELLI, DO11
IRA GROSSMAN, MD11
MICHAEL RITTENBERG, MD11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.